RE:Michael Smedley's top pick:Hopefully this gives us some fuel. Nice to hear for sure.
The problem is not CXR, solid company, solid management, solid growth prospects. It is the macro factors that are causing this.
As it stands we have rallied nicely from today's lows, however, with the Dow continuing to plunge and oil well under $27 I do not think the pain is over yet. I certainly HOPE it is coming to an end soon though. In a normal market this is a no brainer. even in a depressed market fair value is in the $60 ranges.
GLTA
Marcel
spurwing2 wrote: Michael Smedley is executive vice-president and chief investment officer of Morgan Meighen & Associates. His focus is Canadian equities.
Top Picks:
Concordia Healthcare (CXR.TO)
Concordia has undertaken a game-boosting giant acquisition that appears riskless, except for a reasonable opportunity of paying down sizable debt over the next four years. It could easily replace Valeant as the top health-care stock in Canada.